AGENUS INC — Director's Dealing 2022

Jan 4, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2022-01-02

Reporting Person: O'Day Steven J (Chief Medical Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-01-02	Stock Option (Right to Buy)	$3.22	A	150000	Acquired	2022-01-02	Common Stock (150000)	Direct

Footnotes

F1: One-third of the stock options vest on the one-year anniversary of the date of grant, with the remainder vesting in equal quarterly installments thereafter; provided that the Reporting Person maintains a service relationship with the Issuer through each such vesting date.